Cheng, Yiming
https://orcid.org/0000-0001-5428-9418
Mayo Clinic
Bristol-Myers Squibb (United States)
Citations 1
Iberdomide (CC-220) Monotherapy or in Combination with an Anti-CD20 Monoclonal Antibody As Effective Therapy in Patients with Relapsed/Refractory Lymphoma: Early Results from a Phase 1/2 Study
Thiéblemont, Catherine , Visco, Carlo , Gastinne, Thomas , Bouabdallah, Kamal , Nowakowski, Grzegorz S. , Roulin, Louise , Topp, Max S. , Jauhari, Shekeab , Vučinić, Vladan , Martin, Peter , Gkasiamis, Argyrios, Drew, James, Rao, Parth, Cheng, Yiming , Muñoz, Javier , Tucci, Alessandra , Cartron, Guillaume , Corradini, Paolo , Flinn, Ian W. , Arcaini, Luca , Kaplan, Mark H. , Li, Ju, Morschhauser, Franck
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 569-572
